NCT06697106View on ClinicalTrials.gov

Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?

NARecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions
COX-2 InhibitorMeloxicamStricture RecurrenceDirect Vision Internal Urethrotomy
Interventions
DRUG

Nonsteroidal anti-inflammatory drugs

Patients will undergo direct vision internal urethrotomy (DVIU) plus nonsteroidal anti-inflammatory drugs (NSAID) for 3 weeks.

DRUG

Placebo

Patients will undergo direct vision internal urethrotomy (DVIU) plus a placebo for 3 weeks.

Trial Locations (1)

72511

RECRUITING

New Valley University, New Valley

All Listed Sponsors
lead

New Valley University

OTHER